Diabetes and Hypertension
Part of NephTimes Diseases and Conditions
Advertisement
Researchers conducted an analysis to quantify the within-individual variability of albuminuria in patients with T2D.
A survey found that US physicians would like to find new approaches to lowering patients' blood pressure.
Could urinary podocyte stress biomarker be a surrogate marker of podocyte injury in diabetic kidney disease (DKD)?
There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes.
Researchers studied the effect of intensive blood pressure control on the progression of IgAN.
Researchers explored the association between CSVD and CKD plus the potential role of hypertension in this association.
Researchers examined use of clinical decision support systems to decrease blood pressure in hypertensive patients with CKD.
We've all been guilted into ordering inpatient blood pressure meds. Tim Anderson, MD, asks, "Why?"
Kavita Mistry and Marcelle Tuttle will be the American Kidney Fund 2024 Clinical Scientist in Nephrology Fellows.
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD).
AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease.
Patients with diabetic kidney disease face increased risk of end-stage kidney disease and dialysis.
Albuminuria, hypertension, declining kidney function, and an increase in cardiovascular risk are all hallmarks of DKD.
Strategies for the accurate evaluation of the risk of fragility fractures in elderly patients in the early stages of DKD.
Compared with DPP4 inhibitors, SGLT2 inhibitors were associated with a lower risk for the kidney-specific outcome.
In patients with type 2 diabetes mellitus, identifying nondiabetic kidney disease is crucial in delaying progression of CKD.
Development and validation of a model to predict future trajectories in eGFR in adults with type 2 diabetes and CKD.
A 2004 landmark study demonstrated an association between chronic kidney disease and an increased risk of CV events.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.